Abeona Therapeutics Inc
Abeona Therapeutics Inc (ABEO) Option Chain
As of September 22, 2026, Abeona Therapeutics Inc is trading at $5.53, a -4.99% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 70.2%. IV Rank is 3%.
Read more
Tracking the ABEO option chain helps you see every strike and expiry on Abeona Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Abeona Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ABEO options activity at a glance. Use our scanner to monitor the ABEO option chain in real time and filter for the ABEO options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ABEO stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ABEO option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ABEO stock options are being actively traded and where they are not.
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs.
The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Abeona Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ABEO options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ABEO stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile3.97% Subdued
- Market cap (M$)316
- 52 weeks high-27.71%
- 52 weeks low38.25%
- Analyst recommendationStrong Buy
1.00 - Target price$18.88
241.41% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-1.12
- EPS growth next 5 years-27.34%
As of September 22, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 33.51 | 0 | 0 | 1.27 | 1.53 | 0.70 | 4.90 | 4.00 | -31.27 | — | 0.30 | 0.00 | 0.30 | 0 | 26 | 66.49 |
| 49.44 | 20 | 4 | 0.24 | 0.53 | 0.45 | 1.10 | 5.00 | -14.09 | — | 0.50 | 0.00 | 0.50 | 0 | 4 | 50.56 |
| 62.64 | 348 | 70 | 0.25 | 0.00 | — | 0.25 | 6.00 | +3.09 | 0.10 | 4.90 | 0.47 | 2.03 | 4 | 3 | 37.36 |
| 72.80 | 115 | 27 | 0.05 | 0.00 | — | 0.05 | 7.00 | +20.27 | — | 4.90 | 1.47 | 3.43 | 0 | 35 | 27.20 |
| 80.32 | 25 | 0 | 0.05 | 0.00 | — | 0.05 | 8.00 | +37.46 | 0.10 | 4.90 | 2.47 | 0.03 | 0 | 0 | 19.68 |
As of September 22, 2026
Scan the full option chain in one place
Browse the full ABEO option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→